WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New DDDs

List of new DDDs decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the ATC codes should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDDs will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

ATC codeATC level name (INN/generic name)DDDUnit Adm.routeDeadline for objection to temporary DDDs 1) Implementation in ATC/DDD index if no objection is received
A07EA06budesonide2mgSL01.02.20202021
A10BG04lobeglitazone0.5mgO01.02.20202021
B01AX07caplacizumab10mgP01.02.20202021
L04AC17tildrakizumab1.11mgP01.02.20202021
L04AC18risankizumab1.67mgP01.02.20202021
N07BC01buprenorphine2.1mgP01.02.20202021

Last updated: 2019-11-28